Prognostic value of coagulation markers in patients with colorectal cancer: A prospective study by Wenxin Chen, Yueying Li, Weifeng Wang, Yingjun Xue, Jianxin Qian, Weiwei Liu, Xiaobo Hu

Get full text

Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer by Lu Liu, Meiling Long, Shengyuan Su, Lijun Wang, Jintao Liu

“…The pathological N stage, CD3+ TILsIM and CD8+ TILsTC were found to be independent prognostic indicators. …”
Get full text

Resective Surgery versus Debridement in Stage 2 Medication-Related Osteonecrosis of the Jaw by Salvatore D’Amato, Antonio Troiano, Giorgio Lo Giudice, Davide De Cicco, Mario Rusciano, Gianpaolo Tartaro, Giuseppe Colella

“…Health-related quality of life was evaluated by using the European Organization for Research and Treatment of Cancer questionnaires, QLQ-C30 and H&N35. Statistical analysis was performed using Wilcoxon/Mann–Whitney test, Kaplan–Meier test, Cox regression model and Cox multivariate regression. …”
Get full text

Delayed Start of Routine Vaccination in Preterm and Small-for-Gestational-Age Infants: An Area-Based Cohort Study from the Tuscany Region, Italy by Vieri Lastrucci, Monia Puglia, Martina Pacifici, Primo Buscemi, Michela Sica, Giorgia Alderotti, Gilda Belli, Elettra Berti, Franca Rusconi, Fabio Voller

“…To evaluate routine vaccination timeliness in these high-risk groups, a full birth cohort of infants (<i>n</i> = 41,502) born in 2017 and 2018 in Tuscany was retrospectively followed up until 24 months of age. …”
Get full text

MATCHING-ADJUSTED INDIRECT COMPARISON OF PIRTOBRUTINIB VS VENETOCLAX CONTINUOUS MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY CLL PREVIOUSLY TREATED WITH A COVALENT BTK INHIBITO... by O Al-Sawaf, M Jen, LM Hess, J Zhang, B Goebel, JM Pagel, TA Eyre, LYCGN Presenter

“…Materials and methods: Data from pts with R/R CLL previously treated with at least 1 cBTKi and without prior venetoclax exposure who received pirtobrutinib were analyzed (n = 146). Only 1 prospective trial of venetoclax (administered as a continuous monotherapy) for pts previously treated with a cBTKi (n = 91) was identified. …”
Get full text

Marketing madness by Anne Zimmerman

“…Kaplan does not believe deidentification is foolproof and expects that patients would opt out of sharing data for marketing. …”
Get full text

Survival Analysis and Contributing Factors among PCR-Confirmed Adult Inpatients during the Endemic Phase of COVID-19 by Verónica Benites-Godínez, Oliver Mendoza-Cano, Xóchitl Trujillo, Mónica Ríos-Silva, Agustin Lugo-Radillo, Jaime Alberto Bricio-Barrios, Herguin Benjamin Cuevas-Arellano, Eder Fernando Ríos-Bracamontes, Walter Serrano-Moreno, Yolitzy Cárdenas, Greta Mariana Baltazar-Rodríguez, Ana Daniela Ortega-Ramírez, Efrén Murillo-Zamora

Get full text

Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction by Zheng Liu, Zheng Liu, Lei Wang, Qichang Xing, Qichang Xing, Xiang Liu, Xiang Liu, Yixiang Hu, Yixiang Hu, Wencan Li, Wencan Li, Qingzi Yan, Qingzi Yan, Renzhu Liu, Renzhu Liu, Nan Huang

“…The results showed that six CRGs (LIAS, LIPT1, DLAT, PDHB, MTF1, and GLS) were markedly differentially expressed between stable coronary heart disease (stable_CAD) and AMI. …”
Get full text

The prognostic value and immune microenvironment association of AR in HER2+ nonmetastatic breast cancer by Danyang Zhou, Mei Li, Mohamed Hussein Yasin, Qianyi Lu, Jia Fu, Kuikui Jiang, Ruoxi Hong, Shusen Wang, Fei Xu

“…AR+ and AR− breast IDC samples were matched 1:1 in age, T stage, and N stage for immune infiltration analysis. A total of 554 patients with HER2+ nonmetastatic breast cancer were included in this retrospective study, regardless of HR status. …”
Get full text

Integrative Analysis of Angiogenesis-Related Long Non-Coding RNA and Identification of a Six-DEARlncRNA Signature Associated with Prognosis and Therapeutic Response in Esophageal S... by Shasha Cao, Xiaomin Wang, Xiaohui Liu, Junkuo Li, Lijuan Duan, Zhaowei Gao, Shumin Lun, Yanju Zhu, Haijun Yang, Hao Zhang, Fuyou Zhou

“…Optimal lncRNA biomarkers were screened from the training set and the six-DEARlncRNA signature comprising AP000696.2, LINC01711, RP11-70C1.3, AP000487.5, AC011997.1, and RP11-225N10.1 could separate patients into high- and low-risk groups with markedly different survival. …”
Get full text

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma by Gohar Shahwar Manzar, Brian Sandeep De, Chike Osita Abana, Sunyoung S. Lee, Milind Javle, Ahmed O. Kaseb, Jean-Nicolas Vauthey, Hop Sanderson Tran Cao, Albert C. Koong, Grace Li Smith, Cullen M. Taniguchi, Emma Brey Holliday, Prajnan Das, Eugene Jon Koay, Ethan Bernard Ludmir

“…Liver function remained stable post-RT. There was a marked decrease in ALCs immediately post-RT (post-RT/pre-RT ratio 47.3%, <i>p</i> < 0.0001), restored by 1 month to pre-treatment baseline (1-month post-RT/pre-RT ratio 95.1%, n.s.). …”
Get full text

Long‐term retention on antiretroviral treatment after enrolment in prevention of vertical HIV transmission services: a prospective cohort study in Dar es Salaam, Tanzania by Roseline Faustine Urrio, Goodluck Willey Lyatuu, David Sando, Michael J. Mahande, Emmanuel Philipo, Helga Naburi, Peter Lyaruu, Amanda Kimonge, Kasasi Mayogu, Brenda Simba, Ayoub Muhamed Kibao, Michael Msangi, Zangin Zeebari, Gunnel Biberfeld, Anna Mia Ekström, Charles Kilewo, Anna E. Kågesten

Get full text

Recurrence‐free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trials by Emma Vail, Ankur P. Choubey, H. Richard Alexander, David A. August, Abril Berry, Patrick M. Boland, Mariam F. Eskander, Miral S. Grandhi, Brittany Haliani, Haejin In, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Henry A. Pitt, Shridar Ganesan, Brett L. Ecker

Get full text

Intensive neurorehabilitation and allogeneic stem cells transplantation in canine degenerative myelopathy by Débora Gouveia, Débora Gouveia, Débora Gouveia, Jéssica Correia, Jéssica Correia, Ana Cardoso, Ana Cardoso, Carla Carvalho, Ana Catarina Oliveira, Ana Catarina Oliveira, António Almeida, Óscar Gamboa, Lénio Ribeiro, Mariana Branquinho, Mariana Branquinho, Mariana Branquinho, Ana Sousa, Ana Sousa, Ana Sousa, Bruna Lopes, Bruna Lopes, Bruna Lopes, Patrícia Sousa, Patrícia Sousa, Patrícia Sousa, Alícia Moreira, Alícia Moreira, Alícia Moreira, André Coelho, André Coelho, André Coelho, Alexandra Rêma, Alexandra Rêma, Alexandra Rêma, Rui Alvites, Rui Alvites, Rui Alvites, Rui Alvites, António Ferreira, António Ferreira, António Ferreira, Ana Colette Maurício, Ana Colette Maurício, Ana Colette Maurício, Ângela Martins, Ângela Martins, Ângela Martins

“…The INSCP group was hospitalized for 1 month (T0 to T1), followed by MSCs transplantation (T1) and a second month (T2), whereas the ARP group was under ambulatory treatment for the same 2 months.ResultsSurvival mean time of total population was 375 days, with 438 days for the INSCP group and 274 for the ARP group, with a marked difference on the Kaplan–Meier survival analysis. …”
Get full text

Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry by Harald Kaemmerer, Matthias Gorenflo, Dörte Huscher, David Pittrow, Christian Apitz, Helmut Baumgartner, Felix Berger, Leonhard Bruch, Eva Brunnemer, Werner Budts, Martin Claussen, Gerry Coghlan, Ingo Dähnert, Michele D’Alto, Marion Delcroix, Oliver Distler, Sven Dittrich, Daniel Dumitrescu, Ralf Ewert, Martin Faehling, Ingo Germund, Hossein Ardeschir Ghofrani, Christian Grohé, Karsten Grossekreymborg, Michael Halank, Georg Hansmann, Dominik Harzheim, Attila Nemes, Kalman Havasi, Matthias Held, Marius M. Hoeper, Michael Hofbeck, Wolfgang Hohenfrost-Schmidt, Elena Jurevičienė, Lina Gumbienè, Hans-Joachim Kabitz, Hans Klose, Thomas Köhler, Stavros Konstantinides, Martin Köestenberger, Rainer Kozlik-Feldmann, Hans-Heiner Kramer, Cornelia Kropf-Sanchen, Astrid Lammers, Tobias Lange, Philipp Meyn, Oliver Miera, Katrin Milger-Kneidinger, Rhoia Neidenbach, Claus Neurohr, Christian Opitz, Christian Perings, Bjoern Andrew Remppis, Gabriele Riemekasten, Laura Scelsi, Werner Scholtz, Iveta Simkova, Dirk Skowasch, Andris Skride, Gerd Stähler, Brigitte Stiller, Iraklis Tsangaris, Carmine Dario Vizza, Anton Vonk Noordegraaf, Heinrike Wilkens, Hubert Wirtz, Gerhard-Paul Diller, Ekkehard Grünig, Stephan Rosenkranz

“…The 5-year Kaplan–Meier survival estimate for CHD associated PH was significantly better than that for idiopathic PAH (76% vs. 54%; <i>p</i> < 0.001). …”
Get full text